SAP shares rally on strong cloud backlog and antitrust clearance ...
Gold stays resilient despite geopolitical de-escalation ...
Nvidia explores guaranteeing up to $250B in debt for OpenAI's ...
ASML shares trade below 50-day average but Goldman and Bernstein ...
Bioage Labs shares surge 17% on oversold bounce yet investors ...
Heidelberg Materials posts first volume growth in 4 years ...
Novo Nordisk faces a pivotal earnings report as options ...
Micron posts historic 84.9% gross margin and 346% revenue ...
Despite an 11% stock dip TSMC raises 2026 capex to $64B ...
SanDisk shares rebound 3.81% but remain 34% down in 30 days. ...
Novo Nordisk heads into Q2 earnings with diversification ...
IperionX's share price falls 40% YTD despite Pentagon support ...
Kioxia shares surge 9% on buyback stock split and first ...
SK Hynix shares see record swings as profit-taking and leveraged ...
Adidas shares rebound above key support after 12% slide ...
Mutares' busy deal pipeline—Free2move acquisition multiple ...
SAP's cloud growth and buyback fuel a short-term rally yet ...
Microsoft's accounting tweak lowers reported capex to $175B ...
MSCI World ETF closes near record despite whipsaw week; ...
Options market braces for volatile Novo Nordisk earnings ...
Partners Group exits Zabka in $8.6B deal boosting performance ...
ASML shares slide 14% but 2026 EUV capacity is sold out. ...
Nebius holds $40B GPU backlog and Microsoft/Meta deals yet ...
BYD's record July exports mask a 9% domestic sales drop ...
Options signal 8% swing as Novo Nordisk's H1 results loom ...
Microsoft's AI bet pays off: Azure tops $100B AI ARR jumps ...
Xiaomi hikes smartphone prices up to 13% due to memory shortage ...
LVR's 2025 plan details €9.01B in services €3.87B municipal ...
Partners Group's $8.6B ?abka sale aids fee income but redemption ...
SpaceX faces its first earnings as a public company and ...
Siemens Energy's Q3 results hinge on Gamesa free cash flow ...
Novo Nordisk's Ziltivekimab misses primary endpoint in Phase ...
SAP resolves EU and German antitrust probes stock rallies ...
ASML raises 2026 revenue forecast to €43-45B on AI chip ...
Novo Nordisk faces pipeline crisis as Ziltivekimab fails ...
SK Hynix rebounds 22.6% post margin-call crash but HBM4 ...
Deutsche Telekom heads into H1 results with record cash ...
Marvell Technology gains 2.42% after Amazon raises 2026 ...
Amazon's stock jumps 15% as investors back a bold AI-driven ...
BYD's July NEV sales hit a record 419 211 units driven by ...
Novo Nordisk shares near 200-day moving average after Phase ...
SK Hynix rebounds 22.6% after Nvidia partnership and strong ...
Xiaomi delivers 104 559 EVs in H1 2026 launches premium ...
Microsoft's Q3 earnings crush estimates Azure grows 43% ...
Nvidia's stock retreats despite sold-out orders as plans ...
Infineon reports Q3 earnings Aug 5 amid AI-driven growth ...
German employers and insurers launch sports bike leasing ...
Stryker's strong Q2 results were overshadowed by narrowed ...
TSMC posts 36% revenue growth on AI demand targets Intel's ...
Novo Nordisk faces pivotal earnings after heart-drug trial ...
Microsoft's Q4 beat and Azure growth prove AI monetization ...
Heidelberg Materials posts 6% revenue growth but shares ...
Adidas shares fell sharply after Q2 operating profit missed ...
JinkoSolar shares near 52-week low amid Goldman s Sell rating, but Beijing ...
Siemens Energy shares drift below highs as volatility persists; ...
Novo Nordisk's Ziltivekimab misses primary endpoint sending ...
Adidas shares fall 7.7% despite record Q2 revenue; CEO's ...
MSCI World ETF sits 4% from peak as 30-year Treasury yields ...
Novo Nordisk's shares drop 8.5% after Ziltivekimab fails ...
BYD shares climb 18.7% in a month on record exports but ...
FDA clears J&J's Ottava robot for 10 procedures intensifying ...
Allianz acquires remaining 4.4% PIMCO stake from former ...
US PMI and jobs data this week will determine if the Vanguard ...
Novo Nordisk faces pivotal week after Ziltivekimab trial ...
SAP shares surge 13% despite lowered profit outlook driven ...
Commerzbank shifts to constructive merger talks with UniCredit ...
BYD hits record 419 211 July sales with 43% exports unveils ...
VanEck Developed Markets Dividend Leaders ETF sits 0.79% ...
Novo Nordisk faces Q2 2026 report amid Ziltivekimab trial ...
SAP shares surge on strong Q2 cloud revenue and antitrust ...
Commerzbank's Q2 report on Aug 6 will influence UniCredit ...
Nvidia's balance sheet fuels AI boom with $250B OpenAI guarantee ...
Microsoft shares surge 20% in 7 sessions but overbought ...
Novo Nordisk faces Q2 report after Ziltivekimab Phase III ...
BYD faces uphill battle to hit 2026 sales goal as domestic ...
Novo Nordisk faces Phase 3 failure shareholder lawsuit and ...
Adidas posts record Q2 revenue but marketing costs and flat ...
Stryker beats Q2 estimates but shares fall 6.4% on cautious ...
Microsoft sets Sept 2026 auto-migration to passkeys Feb ...
Nokia's €2.8B AI order haul and S&P outlook upgrade fail ...
Novo Nordisk's Ziltivekimab Phase 3 miss erases blockbuster ...
VanEck dividend ETF edges toward all-time high; Exxon weighs ...
SpaceX shares near 52-week low as first earnings as public ...
Court ruling threatens fiber rollout while T-Mobile US stock ...
Microsoft's Azure growth and $678B backlog reassure investors ...
Marvell's custom AI chip duopoly with Broadcom fails to ...
ASML shares slide on China's domestic DUV progress but Bernstein ...
Xiaomi's EV deliveries hit 4 straight months above 30k but ...
Microsoft's record $450B market cap gain on strong Azure ...
Adidas posts record Q2 sales but margin miss and CFO departure ...
Bayer's shares surge 78% on legal wins but pullback signals ...
SAP shares rise 13.45% in seven days after German regulator ...
Europe s top-selling fund barely moved amid KOSPI chaos, proving diversification ...
Deutsche Telekom shares slide 21.8% from highs as T-Mobile ...
BYD prepares to launch its first humanoid robot prototype ...
SK Hynix posts record Q2 profit but misses guidance; shares ...
D-Wave lands AT&T expansion and Nasdaq listing but Q1 revenue ...
Novo Nordisk's Ziltivekimab misses primary endpoint in Phase-3 ...
Clean Air Metals und das von Fiore unterstĂĽtzte Unternehmen ...